We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
National Healthcare
NHC
$3.53B
| $959K | ﹤0.01% |
15,329
-10,287
| -40% | -$663K |
|
2002
Lantheus
LNTH
$6.49B
| $956K | ﹤0.01% |
53,702
+2,560
| +5% | +$45K |
|
2003
James River Group Holdings
JRVR
$208M
| $952K | ﹤0.01% |
22,960
+2,604
| +13% | +$104K |
|
2004
MYR Group
MYRG
$5.19B
| $949K | ﹤0.01% |
32,550
+520
| +2% | +$14.4K |
|
|
GHL
2005
DELISTED
Greenhill & Co., Inc.
GHL
| $947K | ﹤0.01% |
57,035
+840
| +1% | +$14.2K |
|
|
RDUS
2006
DELISTED
Radius Recycling
RDUS
| $945K | ﹤0.01% |
33,563
+62
| +0.2% | +$1.62K |
|
|
COBZ
2007
DELISTED
CoBiz Financial,Inc
COBZ
| $945K | ﹤0.01% |
48,139
+360
| +0.8% | +$6.26K |
|
2008
Alaunos Therapeutics
TCRT
$4.59M
| $939K | ﹤0.01% |
1,020
+13
| +1% | +$11.5K |
|
|
CZR
2009
DELISTED
Caesars Entertainment Corporation
CZR
| $938K | ﹤0.01% |
70,265
+50
| +0.1% | +$606 |
|
|
KTWO
2010
DELISTED
K2M Group Holdings, Inc
KTWO
| $937K | ﹤0.01% |
44,154
+989
| +2% | +$22.9K |
|
|
OSG
2011
Octave Specialty Group
OSG
$243M
| $934K | ﹤0.01% |
54,117
+365
| +0.7% | +$6.74K |
|
2012
Smith & Wesson
SWBI
$651M
| $933K | ﹤0.01% |
79,585
+729
| +0.9% | +$10.3K |
|
|
FPO
2013
DELISTED
First Potomac Realty Trust
FPO
| $930K | ﹤0.01% |
83,470
+1,414
| +2% | +$15.7K |
|
|
DHIL
2014
DELISTED
Diamond Hill
DHIL
| $928K | ﹤0.01% |
4,372
+53
| +1% | +$10.5K |
|
|
HAYN
2015
DELISTED
Haynes International, Inc.
HAYN
| $926K | ﹤0.01% |
25,788
+460
| +2% | +$14.8K |
|
|
XENT
2016
DELISTED
Intersect ENT, Inc
XENT
| $926K | ﹤0.01% |
29,721
+325
| +1% | +$9.62K |
|
2017
Center Bancorp
CNOB
$1.66B
| $920K | ﹤0.01% |
37,406
+390
| +1% | +$8.86K |
|
2018
Vanda Pharmaceuticals
VNDA
$307M
| $919K | ﹤0.01% |
51,321
+600
| +1% | +$10K |
|
|
BKS
2019
DELISTED
Barnes & Noble
BKS
| $917K | ﹤0.01% |
120,641
+1,770
| +1% | +$13.2K |
|
|
HDP
2020
DELISTED
Hortonworks, Inc.
HDP
| $917K | ﹤0.01% |
54,106
+705
| +1% | +$10.6K |
|
2021
Monarch Casino & Resort
MCRI
$2.2B
| $915K | ﹤0.01% |
23,147
+380
| +2% | +$12.8K |
|
|
BKMU
2022
DELISTED
Bank Mutual Corp
BKMU
| $913K | ﹤0.01% |
89,929
+1,400
| +2% | +$13.2K |
|
2023
Regenxbio
RGNX
$620M
| $911K | ﹤0.01% |
27,651
+400
| +1% | +$9K |
|
|
SP
2024
DELISTED
SP Plus Corporation
SP
| $902K | ﹤0.01% |
22,837
+220
| +1% | +$7.73K |
|
2025
Forrester Research
FORR
$223M
| $898K | ﹤0.01% |
21,450
+490
| +2% | +$19.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.